192 related articles for article (PubMed ID: 19636221)
1. Clinical aspects and therapeutic outcome in thyrotropin-secreting pituitary adenomas: a single center experience.
Macchia E; Gasperi M; Lombardi M; Morselli L; Pinchera A; Acerbi G; Rossi G; Martino E
J Endocrinol Invest; 2009 Oct; 32(9):773-9. PubMed ID: 19636221
[TBL] [Abstract][Full Text] [Related]
2. [Thyrotropin-secreting pituitary adenomas].
Caron P
Presse Med; 2009 Jan; 38(1):107-11. PubMed ID: 18980829
[TBL] [Abstract][Full Text] [Related]
3. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
Socin HV; Chanson P; Delemer B; Tabarin A; Rohmer V; Mockel J; Stevenaert A; Beckers A
Eur J Endocrinol; 2003 Apr; 148(4):433-42. PubMed ID: 12656664
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
6. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
[TBL] [Abstract][Full Text] [Related]
7. Surgical Outcome and Treatment of Thyrotropin-Secreting Pituitary Tumors in a Tertiary Referral Center.
Herguido NG; Fuentes ED; Venegas-Moreno E; Maorad LB; Flores-Martinez A; Ruiz PR; Dueñas MC; Roldán F; Fajardo E; Ruiz-Valdepeñas EC; Kaen A; Martín Schrader I; Cano DA; Soto-Moreno A
World Neurosurg; 2019 Oct; 130():e634-e639. PubMed ID: 31276853
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of TSH-secreting adenomas: review of a longtime experience in a reference center.
Nazato DM; Abucham J
J Endocrinol Invest; 2018 Apr; 41(4):447-454. PubMed ID: 29022276
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?
Gatto F; Grasso LF; Nazzari E; Cuny T; Anania P; Di Somma C; Colao A; Zona G; Weryha G; Pivonello R; Ferone D
Pituitary; 2015 Oct; 18(5):583-91. PubMed ID: 25326851
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-stimulating hormone pituitary adenomas.
Clarke MJ; Erickson D; Castro MR; Atkinson JL
J Neurosurg; 2008 Jul; 109(1):17-22. PubMed ID: 18590428
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis, pathology, and management of TSH-secreting pituitary tumors. A single-center retrospective study of 20 patients from 1981 to 2014.
Căpraru OM; Gaillard C; Vasiljevic A; Lasolle H; Borson-Chazot F; Raverot V; Jouanneau E; Trouillas J; Raverot G
Ann Endocrinol (Paris); 2019 Sep; 80(4):216-224. PubMed ID: 31400861
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing Thyrotropin-Secreting Pituitary Adenomas by Short-Term Somatostatin Analogue Test.
Han R; Shen L; Zhang J; Xie J; Fang W; Sun Q; Bian L; Zhou Y; Wang S; Ning G; Wang W; Ye L
Thyroid; 2020 Sep; 30(9):1236-1244. PubMed ID: 32212919
[No Abstract] [Full Text] [Related]
13. [Thyrotropin--TSH secreting pituitary tumor].
Zieliński G; Podgórski JK; Warczyńska A; Koziarski A; Zgliczyński W
Przegl Lek; 2002; 59(12):1018-23. PubMed ID: 12731380
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of thyrotropin-secreting pituitary adenomas.
Losa M; Mortini P; Franzin A; Barzaghi R; Mandelli C; Giovanelli M
Pituitary; 1999 Aug; 2(2):127-31. PubMed ID: 11081163
[TBL] [Abstract][Full Text] [Related]
15. [Thyrotropin-secreting pituitary adenomas: clinical features and results of treatment in 45 patients].
Trukhina DA; Przhiyalkovskaya EG; Belaya ZE; Grigoriev AY; Azizyan VN; Mamedova EO; Rozhinskaya LY; Lapshina AM; Pigarova EA; Dzeranova LK; Platonova NM; Troshina EA; Melnichenko GA
Probl Endokrinol (Mosk); 2023 Sep; 70(2):23-36. PubMed ID: 38796758
[TBL] [Abstract][Full Text] [Related]
16. Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center.
Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
Front Endocrinol (Lausanne); 2022; 13():1061029. PubMed ID: 36518240
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
Kuhn JM; Arlot S; Lefebvre H; Caron P; Cortet-Rudelli C; Archambaud F; Chanson P; Tabarin A; Goth MI; Blumberg J; Catus F; Ispas S; Beck-Peccoz P
J Clin Endocrinol Metab; 2000 Apr; 85(4):1487-91. PubMed ID: 10770186
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients.
Gesundheit N; Petrick PA; Nissim M; Dahlberg PA; Doppman JL; Emerson CH; Braverman LE; Oldfield EH; Weintraub BD
Ann Intern Med; 1989 Nov; 111(10):827-35. PubMed ID: 2479309
[TBL] [Abstract][Full Text] [Related]
19. Pituitary macroadenoma secreting thyrotropin and growth hormone: remission of bihormonal hypersecretion in response to lanreotide therapy.
Shimon I; Nass D; Gross DJ
Pituitary; 2001 Sep; 4(4):265-9. PubMed ID: 12501978
[TBL] [Abstract][Full Text] [Related]
20. Long term treatment of a thyrotropin-secreting microadenoma with somatostatin analogues.
Prieto-Tenreiro A; Díaz-Guardiola P
Arq Bras Endocrinol Metabol; 2010; 54(5):502-6. PubMed ID: 20694413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]